(DOX) Amdocs - Overview

Sector: Technology | Industry: Software - Infrastructure | Exchange: NASDAQ (USA) | Market Cap: 6.731m USD | Total Return: -31.3% in 12m

Billing Software, CRM, Network Automation, Cloud Services, Managed Services
Total Rating 42
Safety 75
Buy Signal -0.25
Software - Infrastructure
Industry Rotation: +27.8
Market Cap: 6.73B
Avg Turnover: 66.6M
Risk 3d forecast
Volatility28.3%
VaR 5th Pctl5.01%
VaR vs Median7.56%
Reward TTM
Sharpe Ratio-1.59
Rel. Str. IBD10.2
Rel. Str. Peer Group44.6
Character TTM
Beta0.549
Beta Downside0.731
Hurst Exponent0.517
Drawdowns 3y
Max DD35.23%
CAGR/Max DD-0.34
CAGR/Mean DD-1.00
EPS (Earnings per Share) EPS (Earnings per Share) of DOX over the last years for every Quarter: "2021-03": 1.13, "2021-06": 1.35, "2021-09": 1.16, "2021-12": 1.2, "2022-03": 1.54, "2022-06": 1.27, "2022-09": 1.29, "2022-12": 1.45, "2023-03": 1.47, "2023-06": 1.57, "2023-09": 1.42, "2023-12": 1.56, "2024-03": 1.56, "2024-06": 1.62, "2024-09": 1.7, "2024-12": 1.66, "2025-03": 1.78, "2025-06": 1.72, "2025-09": 1.83, "2025-12": 1.81, "2026-03": 0,
EPS CAGR: -44.53%
EPS Trend: -15.6%
Last SUE: -4.00
Qual. Beats: -1
Revenue Revenue of DOX over the last years for every Quarter: 2021-03: 1048.734, 2021-06: 1066.254, 2021-09: 1087.309, 2021-12: 1104.632, 2022-03: 1145.271, 2022-06: 1160.29, 2022-09: 1166.504, 2022-12: 1185.72, 2023-03: 1223.304, 2023-06: 1235.962, 2023-09: 1242.564, 2023-12: 1245.199, 2024-03: 1245.849, 2024-06: 1250.059, 2024-09: 1263.882, 2024-12: 1110.055, 2025-03: 1128.203, 2025-06: 1144.437, 2025-09: 1150.218, 2025-12: 1155.939, 2026-03: null,
Rev. CAGR: 0.25%
Rev. Trend: -19.2%
Last SUE: 0.40
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: DOX Amdocs

Amdocs Limited (DOX) provides cloud-based software and managed services primarily to the global communications and media industries. The company utilizes a Software-as-a-Service (SaaS) and professional services model to manage mission-critical functions including customer relationship management (CRM), billing, and network orchestration. Its current product strategy centers on CES25, a telco-native suite integrating Generative AI (GenAI) to automate customer engagement and operational workflows.

The company operates within the IT consulting and services sector, where long-term managed services contracts often provide high revenue visibility and deep integration with client infrastructure. As telecommunications providers transition to 5G and cloud-native architectures, Amdocs facilitates this migration through its modular suites for eSIM management, digital monetization, and intelligent networking. Investors may find ValueRay useful for evaluating how these recurring service models impact long-term valuation.

Founded in 1982 and headquartered in Saint Louis, Missouri, Amdocs supports service providers through the entire lifecycle of digital transformation. Its portfolio extends to quality engineering, system integration, and data analytics, positioning the firm as a comprehensive technology partner for large-scale network operators worldwide.

Headlines to Watch Out For
  • Cloud migration and modernization projects drive long-term recurring service revenue growth
  • North American carrier capital expenditure cycles dictate short-term contract booking velocity
  • GenAI-led software suite adoption expands operating margins through automation efficiency
  • Managed services contract renewals provide stable cash flow amid macroeconomic volatility
  • Consolidation among major telecommunication providers reduces the total addressable customer base
Piotroski VR‑10 (Strict) 8.0
Net Income: 571.9m TTM > 0 and > 6% of Revenue
FCF/TA: 0.12 > 0.02 and ΔFCF/TA 3.03 > 1.0
NWC/Revenue: 1.81% < 20% (prev 4.56%; Δ -2.74% < -1%)
CFO/TA 0.14 > 3% & CFO 863.7m > Net Income 571.9m
Net Debt (704.5m) to EBITDA (950.6m): 0.74 < 3
Current Ratio: 1.06 > 1.5 & < 3
Outstanding Shares: last quarter (108.5m) vs 12m ago -4.34% < -2%
Gross Margin: 37.60% > 18% (prev 0.36%; Δ 3.72k% > 0.5%)
Asset Turnover: 72.46% > 50% (prev 77.38%; Δ -4.91% > 0%)
Interest Coverage Ratio: 17.35 > 6 (EBITDA TTM 950.6m / Interest Expense TTM 43.3m)
Altman Z'' 7.28
A: 0.01 (Total Current Assets 1.54b - Total Current Liabilities 1.46b) / Total Assets 6.34b
B: 1.15 (Retained Earnings 7.27b / Total Assets 6.34b)
C: 0.12 (EBIT TTM 750.8m / Avg Total Assets 6.32b)
D: 2.53 (Book Value of Equity 7.29b / Total Liabilities 2.88b)
Altman-Z'' Score: 7.28 = AAA
Beneish M -3.12
DSRI: 1.03 (Receivables 962.8m/990.9m, Revenue 4.58b/4.87b)
GMI: 0.96 (GM 37.60% / 35.95%)
AQI: 1.01 (AQ_t 0.61 / AQ_t-1 0.60)
SGI: 0.94 (Revenue 4.58b / 4.87b)
TATA: -0.05 (NI 571.9m - CFO 863.7m) / TA 6.34b)
Beneish M-Score: -3.12 (Cap -4..+1) = AA
What is the price of DOX shares? As of May 17, 2026, the stock is trading at USD 60.58 with a total of 1,311,065 shares traded.
Over the past week, the price has changed by -4.97%, over one month by -7.47%, over three months by -10.67% and over the past year by -31.32%.
Is DOX a buy, sell or hold? Amdocs has received a consensus analysts rating of 4.71. Therefore, it is recommended to buy DOX.
  • StrongBuy: 5
  • Buy: 2
  • Hold: 0
  • Sell: 0
  • StrongSell: 0
What are the forecasts/targets for the DOX price?
Analysts Target Price 90.2 48.9%
Amdocs (DOX) - Fundamental Data Overview as of 14 May 2026
P/E Trailing = 12.1025
P/E Forward = 8.4674
P/S = 1.47
P/B = 2.0042
P/EG = 0.9411
Revenue TTM = 4.58b USD
EBIT TTM = 750.8m USD
EBITDA TTM = 950.6m USD
Long Term Debt = 647.1m USD (from longTermDebt, last quarter)
Short Term Debt = 167.8m USD (from shortTermDebt, last quarter)
Debt = 952.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 704.5m USD (from netDebt column, last quarter)
Enterprise Value = 7.44b USD (6.73b + Debt 952.4m - CCE 247.9m)
Interest Coverage Ratio = 17.35 (Ebit TTM 750.8m / Interest Expense TTM 43.3m)
EV/FCF = 9.85x (Enterprise Value 7.44b / FCF TTM 754.9m)
FCF Yield = 10.15% (FCF TTM 754.9m / Enterprise Value 7.44b)
FCF Margin = 16.49% (FCF TTM 754.9m / Revenue TTM 4.58b)
Net Margin = 12.49% (Net Income TTM 571.9m / Revenue TTM 4.58b)
Gross Margin = 37.60% ((Revenue TTM 4.58b - Cost of Revenue TTM 2.86b) / Revenue TTM)
Gross Margin QoQ = 37.04% (prev 37.38%)
Tobins Q-Ratio = 1.17 (Enterprise Value 7.44b / Total Assets 6.34b)
Interest Expense / Debt = 1.18% (Interest Expense 11.3m / Debt 952.4m)
Taxrate = 18.91% (37.0m / 195.4m)
NOPAT = 608.8m (EBIT 750.8m * (1 - 18.91%))
Current Ratio = 1.06 (Total Current Assets 1.54b / Total Current Liabilities 1.46b)
Debt / Equity = 0.28 (Debt 952.4m / totalStockholderEquity, last quarter 3.42b)
Debt / EBITDA = 0.74 (Net Debt 704.5m / EBITDA 950.6m)
Debt / FCF = 0.93 (Net Debt 704.5m / FCF TTM 754.9m)
Total Stockholder Equity = 3.45b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.05% (Net Income 571.9m / Total Assets 6.34b)
RoE = 16.56% (Net Income TTM 571.9m / Total Stockholder Equity 3.45b)
RoCE = 18.31% (EBIT 750.8m / Capital Employed (Equity 3.45b + L.T.Debt 647.1m))
RoIC = 14.73% (NOPAT 608.8m / Invested Capital 4.13b)
WACC = 7.05% (E(6.73b)/V(7.68b) * Re(7.91%) + D(952.4m)/V(7.68b) * Rd(1.18%) * (1-Tc(0.19)))
Discount Rate = 7.91% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: -85.40 | Cagr: -3.98%
[DCF] Terminal Value 82.86% ; FCFF base≈676.3m ; Y1≈720.3m ; Y5≈866.6m
[DCF] Fair Price = 169.4 (EV 18.93b - Net Debt 704.5m = Equity 18.22b / Shares 107.6m; r=7.05% [WACC]; 5y FCF grow 7.21% → 3.0% )
EPS Correlation: -15.61 | EPS CAGR: -44.53% | SUE: -4.0 | # QB: -1
Revenue Correlation: -19.24 | Revenue CAGR: 0.25% | SUE: 0.40 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.89 | Chg30d=+0.13% | Revisions=+14% | Analysts=3
EPS current Year (2026-09-30): EPS=7.48 | Chg30d=+0.17% | Revisions=+20% | GrowthEPS=+7.0% | GrowthRev=+3.4%
EPS next Year (2027-09-30): EPS=8.11 | Chg30d=+0.09% | Revisions=-20% | GrowthEPS=+8.4% | GrowthRev=+3.5%
[Analyst] Revisions Ratio: +20%